Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease-Reference-Cited by-同舟云学术

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease

Published:2016-02-08 Issue:10 Volume:75 Page:1797-1805
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Michaud Kaleb^ORCID,Berglind Niklas,Franzén Stefan,Frisell Thomas^ORCID,Garwood Christopher,Greenberg Jeffrey D,Ho Meilien,Holmqvist Marie,Horne Laura,Inoue Eisuke,Nyberg Fredrik^ORCID,Pappas Dimitrios A,Reed George,Symmons Deborah^ORCID,Tanaka Eiichi,Tran Trung N,Verstappen Suzanne M M,Wesby-van Swaay Eveline,Yamanaka Hisashi,Askling Johan

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference26 articles.

1. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis;Dadoun;Joint Bone Spine,2013

2. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study;Lindhardsen;Ann Rheum Dis,2011

3. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis;Peters;Ann Rheum Dis,2010

4. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients;Arts;Ann Rheum Dis,2015

5. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFa inhibitors and rituximab;Listing;Ann Rheum Dis,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New and Emerging Therapies: Review the Latest Advancements in Rheumatology Treatments, Including Biologic Therapies, Targeted Therapies, Regenerative Medicine, and Novel Drug Development, Assessing their Potential Benefits and Limitations;Journal of Community Pharmacy Practice;2024-08-12

2. Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database;RMD Open;2024-06

3. Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort;Rheumatology;2023-06-28

4. Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study;Rheumatology;2021-01-07

Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results

;Open Access Rheumatology: Research and Reviews;2020-11